
Siegfried Investor Relations Material
Latest events

H1 2025
Siegfried
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Siegfried Holding AG
Access all reports
Siegfried Holding AG is a pharmaceutical company that provides development and manufacturing services for the pharmaceutical industry. The company specializes in the production of active pharmaceutical ingredients (APIs), intermediates, and finished drug products. Siegfried supports its clients across the entire value chain, from chemical development and scale-up to the production of commercial-scale pharmaceuticals. The company's services cater to various pharmaceutical sectors, including both small molecules and biologics. Siegfried operates manufacturing facilities and research centers globally, focusing on efficient and sustainable pharmaceutical production. The company is headquartered in Zofingen, Switzerland, and its shares are listed on the SIX.
Key slides for Siegfried Holding AG


CMD 2024
Siegfried Holding AG


CMD 2024
Siegfried Holding AG
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SFZN
Country
🇨🇭 Switzerland